Recent studies using CGM (or flash glucose monitoring, FGM) during RF have confirmed an increased time in hyperglycemia and glucose variability, especially in subjects with type 1 diabetes receiving insulin therapy [15,16,17]. Here, INS is linked to Hyperglycemia.